Legal protection for children with metabolic syndrome

Abstract

Children are one of the most important groups on whom hope is pinned for building society's future. Despite their importance, they are also one of the weakest and most sensitive links in society. Therefore, they have become the focus of international and national legislation, particularly when it comes to the child's right to life, which represents the foundation from which the right to prevention and health care stems. This right is one of the most important rights that must be recognized for children, as it relates to their healthy and living existence.

The importance of this right increases when the child is ill, especially if this disease is one of the common metabolism diseases that some newborn children are exposed to, which are often genetically diseases, occurring when the child's body cannot deal with nutrients such as fats, proteins, or sugars properly, which may exacerbate to reach the degree of destruction of the digestive system, the brain damage, and even death, but the early detection of it, Providing ways to treat them may contribute to protecting children from their dangers and saving their lives.

It is well known that international legislation, represented by international agreements, declarations, global covenants, and current Iraqi legislation, has been keen to establish certain rights and provide a type of legal protection for children in general. However, the question arises as to whether this protection has been provided for children with metabolic diseases? We will attempt to answer this question throughout the pages of this research, which consists of an introduction, two sections, and a conclusion. In the introduction, we provided an introductory introduction to the research topic, and clarified its problem, scope, methodology, objectives, and plan. We devoted the first section to explaining the concept of metabolic diseases, and we devoted the second section to clarifying the adequacy of legal protection available to children with metabolic diseases. We concluded it with a conclusion in which we summarized the most important findings and proposals we reached through this research